Advertisement

Zinc and the Altered Immune System in the Elderly

  • Hajo Haase
  • Lothar Rink
Part of the Medical Intelligence Unit book series (MIUN)

Abstract

Immune function is severely compromised during states of zinc deficiency. A general observation in elderly people is a reduced serum/plasma zinc level. The decline of immune function with aging, so-called immunosenescence, has several parallels with immunological alterations observed during zinc deficiency; thus, it is plausible that both events are associated, implying an impact of altered zinc status on immune function in the elderly. This is supported by several studies showing that zinc supplementation has a beneficial effect on immune function of elderly people and reverses several changes associated with immunosenescence. This chapter therefore argues that zinc deficiency contributes to immunosenescence.

Keywords

Zinc Deficiency Zinc Level Zinc Supplementation Natural Killer Cell Activity Serum Zinc 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993; 73(1):79–118.PubMedGoogle Scholar
  2. 2.
    Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997; 18(11):519–521.PubMedCrossRefGoogle Scholar
  3. 3.
    Rink L, Gabriel P. Extracellular and immunological actions of zinc. Biometals 2001; 14(3–4):367–383.PubMedCrossRefGoogle Scholar
  4. 4.
    Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39(5):687–699.PubMedCrossRefGoogle Scholar
  5. 5.
    Brown KH. Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. Am J Clin Nutr 1998; 68(2):425S–429S.PubMedGoogle Scholar
  6. 6.
    Zoli A, Altomonte L, Caricchio R et al. Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 1998; 17(5):378–382.PubMedCrossRefGoogle Scholar
  7. 7.
    Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976; 2(7985):539–542.PubMedCrossRefGoogle Scholar
  8. 8.
    Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998; 17(2):109–115.PubMedGoogle Scholar
  9. 9.
    Haase H, Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 2005; 18(4):333–338.PubMedCrossRefGoogle Scholar
  10. 10.
    Schott-Ohly P, Lgssiar A, Partke HJ et al. Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-kappa B and AP-1 in islets, respectively. Exp Biol Med (Maywood) 2004; 229(11):1177–1185.Google Scholar
  11. 11.
    Briefel RR, Bialostosky K, Kennedy-Stephenson J et al. Zinc intake of the US population: findings from the third National Health and Nutrition Examination Survey, 1988–1994. J Nutr 2000; 130:1367S–1373S.PubMedGoogle Scholar
  12. 12.
    Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Eleme Med Biol 2006; 20(1):3–18.CrossRefGoogle Scholar
  13. 13.
    Lindeman RD, Clark ML, Colmore JP. Influence of age and sex on plasma and red-cell zinc concentrations. J Gerontol 1971; 26:358–363.PubMedGoogle Scholar
  14. 14.
    Hotz C, Peerson JM, Brown KH. Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data (1976–1980). Am J Clin Nutr 2003; 78:756–764.PubMedGoogle Scholar
  15. 15.
    Prasad AS, Fitzgerald JT, Hess JW et al. Zinc deficiency in elderly patients. Nutrition 1993; 9:218–224.PubMedGoogle Scholar
  16. 16.
    Goode HF, Penn ND, Kelleher J et al. Evidence of cellular zinc depletion in hospitalized but not in healthy elderly subjects. Age Ageing 1991; 20:345–348.PubMedCrossRefGoogle Scholar
  17. 17.
    Wörwag M, Classen HG, Schumacher E. Prevalence of magnesium and zinc deficiencies in nursing home residents in Germany. Magnes Res 1999; 12:181–189.PubMedGoogle Scholar
  18. 18.
    Pepersack T, Rotsaert P, Benoit F et al. Prevalence of zinc deficiency and its clinical relevance among hospitalized elderly. Arch Gerontol Geriatr 2001; 33:243–253.PubMedCrossRefGoogle Scholar
  19. 19.
    Girodon F, Blache D, Monget AL et al. Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am Coll Nutr 1997; 16:357–365.PubMedGoogle Scholar
  20. 20.
    Bogden JD, Oleske JM, Munves EM et al. Zinc and immunocompetence in the elderly: baseline data on zinc nutriture and immunity in unsupplemented subjects. Am J Clin Nutr 1987; 46:101–109.PubMedGoogle Scholar
  21. 21.
    Kreft B, Fischer A, Kruger S et al. The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency. Biogerontology 2000; 1:61–66.PubMedCrossRefGoogle Scholar
  22. 22.
    Kaplan J, Hess JW, Prasad AS. Impaired interleukin-2 production in the elderly: association with mild zinc deficiency. J Trace Elem Exp Med 1988; 1:3–8.Google Scholar
  23. 23.
    Ibs KH, Gabriel P, Rink L. Zinc and the immune system of elderly. Adv Cell Aging Gerontol 2003; (13):243–259.Google Scholar
  24. 24.
    Schröder AK, Rink L. Neutrophil immunity of the elderly. Mech Ageing Dev 2003; 124(4):419–425.PubMedCrossRefGoogle Scholar
  25. 25.
    Allen JI, Perri RT, McClain CJ et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983; 102(4):577–589.PubMedGoogle Scholar
  26. 26.
    Keen CL, Gershwin ME. Zinc deficiency and immune function. Annu Rev Nutr 1990; 10:415–431.PubMedCrossRefGoogle Scholar
  27. 27.
    Sansoni P, Cossarizza A, Brianti V et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993; 82(9):2767–2773.PubMedGoogle Scholar
  28. 28.
    Solana R, Mariani E. NK and NK/T-cells in human senescence. Vaccine 2000; 18(16):1613–1620.PubMedCrossRefGoogle Scholar
  29. 29.
    Tapazoglou E, Prasad AS, Hill G et al. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. J Lab Clin Med 1985; 105(1):19–22.PubMedGoogle Scholar
  30. 30.
    Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004; 24:277–298.PubMedCrossRefGoogle Scholar
  31. 31.
    Kury S, Dreno B, Bezieau S et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002; 31(3):239–s40.PubMedCrossRefGoogle Scholar
  32. 32.
    Beck FW, Prasad AS, Kaplan J et al. Changes in cytokine production and T-cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997; 272(6):E1002–1007.PubMedGoogle Scholar
  33. 33.
    Liu CG, Zhang L, Jiang Y et al. Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment. Cancer Res 2005; 65(17):7790–7799.PubMedGoogle Scholar
  34. 34.
    Doerr TD, Prasad AS, Marks SC et al. Zinc deficiency in head and neck cancer patients. J Am Coll Nutr 1997; 16(5):418–422.PubMedGoogle Scholar
  35. 35.
    Jarrard DJ. Does zinc supplementation increase the risk of prostate cancer? Arch Ophtalmol 2005; 123:102–103.CrossRefGoogle Scholar
  36. 36.
    Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998; 102(2–3):199–209.PubMedCrossRefGoogle Scholar
  37. 37.
    Cakman I, Rohwer J, Schutz RM et al. Dysregulation between TH1 and TH2 T-cell subpopulations in the elderly. Mech Ageing Dev 1996; 87(3):197–209.PubMedCrossRefGoogle Scholar
  38. 38.
    Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000; 182(1): S62–S68.PubMedCrossRefGoogle Scholar
  39. 39.
    Bao B, Prasad AS, Beck FW et al. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 2003; 285(5):E1095–E1102.PubMedGoogle Scholar
  40. 40.
    Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002; 37(2–3):235–247.PubMedCrossRefGoogle Scholar
  41. 41.
    von Bülow V, Rink L, Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3′, 5′-cyclic monophosphate. J Immunol 2005; 175(7):4697–4705.Google Scholar
  42. 42.
    Cakman I, Kirchner H, Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 1997; 17(8):469–472.PubMedCrossRefGoogle Scholar
  43. 43.
    Fortes C, Forastiere F, Agabiti N et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998; 46:19–26.PubMedGoogle Scholar
  44. 44.
    Duchateau J, Delepesse G, Vrijens R et al. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981; 70:1001–1004.PubMedCrossRefGoogle Scholar
  45. 45.
    Wagner PA, Jernigan JA, Bailey LB et al. Zinc nutriture and cell-mediated immunity in the aged. Int J Vit Nutr Res 1983; 53:94–101.Google Scholar
  46. 46.
    Cossack ZT. T-lymphocyte dysfunction in the elderly associated with zinc deficiency and subnormal nucleoside phosphorylase activity: effect of zinc supplementation. Eur J Cancer Clin Oncol 1989; 25:973–976.PubMedCrossRefGoogle Scholar
  47. 47.
    Bogden JD, Oleske JM, Lavenhar MA et al. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr 1990; 9:214–225.PubMedGoogle Scholar
  48. 48.
    Boukaiba N, Flament C, Acher S et al. A physiological amount of zinc supplementation: effects on nutritional, lipid and thymic status in an elderly population. Am J Clin Nutr 1993; 57:566–572.PubMedGoogle Scholar
  49. 49.
    Fabris N, Mocchegiani E, Amadio L et al. Thymic hormone deficiency in normal ageing and Down’s syndrome: is there a primary failure of the thymus? Lancet 1984; 1:983–986.PubMedCrossRefGoogle Scholar
  50. 50.
    Arreaza EE, Gibbons JJ, Siskind GW et al. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans. Clin Exp Immunol 1993; 92(1):169–173.PubMedCrossRefGoogle Scholar
  51. 51.
    Powers DC, Belshe RB. Effect of age on cytotoxic T-lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993; 167(3):584–992.PubMedGoogle Scholar
  52. 52.
    Girodon F, Galan P, Monget AL et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999; 159:748–754.PubMedCrossRefGoogle Scholar
  53. 53.
    Faber C, Gabriel P, Ibs KH et al. Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response. Bone Marrow Transplant 2004; 33(12):1241–1246.PubMedCrossRefGoogle Scholar
  54. 54.
    Driessen C, Hirv K, Rink L et al. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res 1994; 13(1):15–20.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  • Hajo Haase
    • 1
  • Lothar Rink
    • 1
  1. 1.Institute of Immunology, University HospitalRWTH Aachen UniversityAachenGermany

Personalised recommendations